Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Th17 Cells Blood Proportions Are Influenced by Factors Associated with CRP Serum Level Increase and with NOD2/CARD15 Gene Mutation

Andrzej Lange, MD, DSci, Sylwia Mizia, MSci, Jolanta Bochenska, MSci, Przemyslaw Czajka, MSci, Janusz Lange, MD, Monika Mordak, MD, Dorota Dlubek, PhD

Blood (2012) 120 (21): 4487.

https://doi.org/10.1182/blood.V120.21.4487.4487

Published: 2012

Journal Articles

HSCT PATIENTS with HHV6 Reactivation HAD LOW NUMBERS of CD4+ Effector Memory Lymphocytes IN BLOOD WHAT Associates with Rather POOR SURVIVAL.

Janusz Lange, MD, Daria Drabczak-Skrzypek, Dorota Dlubek, Emilia Jaskula, Dariusz Wolowiec, Andrzej Lange, MD

Blood (2010) 116 (21): 4555.

https://doi.org/10.1182/blood.V116.21.4555.4555

Published: 2010

Journal Articles

Gene Expression for Chemokine Receptors Influences Survival of Non-Hodgkin Lymphoma Patients

Grzegorz Mazur, Emilia Jaskula, Ilona Kryczek, Dorota Dlubek, Tomasz Wrobel, MD, PhD, Aleksandra Butrym, Andrzej Lange, MD, Kazimierz Kuliczkowski

Blood (2010) 116 (21): 3103.

https://doi.org/10.1182/blood.V116.21.3103.3103

Published: 2010

Journal Articles

HHV-6 Reactivation Lowers the Risk of Acute Graft-Versus-Host Disease but Enhances the Risk of Infections Due to Activation of CD4+FoxP3+ Lymphocytes.

Andrzej Lange, MD, PhD, Emilia Jaskula, Sylwia Madej, Dorota Dlubek, PhD

Blood (2009) 114 (22): 4653.

https://doi.org/10.1182/blood.V114.22.4653.4653

Published: 2009

Journal Articles

Proportion of IL-17A Producing CD4+ Cells Increases in Response to Alloreactivity as Part of a Network Involving Memory and Regulatory Cells Post HSCT.

Andrzej Lange, MD, PhD, Dorota Dlubek, PhD, Krzysztof Suchnicki, Sylwia Madej, Eliza Turlej

Blood (2009) 114 (22): 1160.

https://doi.org/10.1182/blood.V114.22.1160.1160

Published: 2009

Journal Articles

Increase in Proportion of Th-17 Lymphocytes in Blood Heralds Overt Acute Graft Versus Host Disease in HSCT Patients.

Andrzej Lange, MD, PhD, Dorota Dlubek, PhD, Emilia Jaskula, Daria Drabczak-Skrzypek, Mariola Sedzimirska, MD, PhD, Janusz Lange, MD

Blood (2008) 112 (11): 2226.

https://doi.org/10.1182/blood.V112.11.2226.2226

Published: 2008

Journal Articles

Increased Interleukin-17 Proportion in Helper T Cell (Th17) in Patients Post Allogeneic Hematopoietic Stem Cell Transplantation.

Andrzej Lange, Dorota Dlubek, PhD, Mariola Sedzimirska, Dr.med.Sci, Daria Drabczak-Skrzypek, MSci, Emilia Jaskula, MSci, Janusz Lange, MD

Blood (2007) 110 (11): 4971.

https://doi.org/10.1182/blood.V110.11.4971.4971

Published: 2007

Journal Articles

CCL2 Chemokine Gene Expression in Lymph Nodes May Have Prognostic Value in Non-Hodgkin’s Lymphoma.

Grzegorz Mazur, MD, PhD, Ilona Kryczek, PhD, Tomasz Wrobel, MD,PhD, Dorota Dlubek, MD,PhD, Aleksandra Klimczak, PhD, Emilia Jaskula, PhD, Michal Jelen, Andrzej Lange, Kazimierz Kuliczkowski

Blood (2006) 108 (11): 4644.

https://doi.org/10.1182/blood.V108.11.4644.4644

Published: 2006

Journal Articles

CCR5 Chemokine Receptor Expression Can Promote Disease Progression in Non-Hodgkin’s Lymphoma.

Grzegorz Mazur, MD, PhD, Ilona Kryczek, PhD, Tomasz Wrobel, MD,PhD, Dorota Dlubek, PhD, Aleksandra Klimczak, PhD, Emilia Jaskula, Michal Jelen, Andrzej Lange, Kazimierz Kuliczkowski

Blood (2006) 108 (11): 4645.

https://doi.org/10.1182/blood.V108.11.4645.4645

Published: 2006

Journal Articles

A High Proportion of CD4+CD25+ Lymphocytes Associates with a Risk of aGvHD and Inversely Correlate with Proportions of CMV and EBV Specific CD8+ Cells in Blood.

Andrzej Lange, PhD, MD, Dorota Dlubek, PhD, Daria Drabczak-Skrzypek, MSCi, Emilia Jaskula, MSCi, Dorota Duda, PhD

Blood (2006) 108 (11): 2855.

https://doi.org/10.1182/blood.V108.11.2855.2855

Published: 2006

Journal Articles

Low Dose Busulfan and ATG with Fludarabine as Conditioning Regimen Was Effective in Sibling and Unrelated Donor HSCT in CML Patients.

Andrzej Lange, PhD, MD, Mariola Sedzimirska, PhD, Dorota Dlubek, PhD, Emilia Jaskula, MSci, Anna Mlynarczewska, MSci, Agnieszka Sok, MSci

Blood (2006) 108 (11): 4808.

https://doi.org/10.1182/blood.V108.11.4808.4808

Published: 2006

Journal Articles

An Evidence That Mesenchymal Stem Cells Are Not Replaced by Peripheral Blood Stem Cell Allografts in CML Patients.

Andrzej Lange, Dorota Dlubek, Barbara Wysoczanska, Daria Drabczak-Skrzypek, Emilia Jaskula

Blood (2005) 106 (11): 4875.

https://doi.org/10.1182/blood.V106.11.4875.4875

Published: 2005

Journal Articles

Marrow Cells Cultured in MSC Medium Expand to CD73, CD90 and CD105 Cells of Fibroblast-Like Morphology.

Andrzej Lange, MD, PhD, Dorota Dlubek, MD, Daria Drabczak-Skrzypek, MD, K. Bogunia-Kubik, MD, Emilia, MD

Blood (2005) 106 (11): 4319.

https://doi.org/10.1182/blood.V106.11.4319.4319

Published: 2005

NARROW

Th17 Cells Blood Proportions Are Influenced by Factors Associated with CRP Serum Level Increase and with NOD2/CARD15 Gene Mutation

HSCT PATIENTS with HHV6 Reactivation HAD LOW NUMBERS of CD4+ Effector Memory Lymphocytes IN BLOOD WHAT Associates with Rather POOR SURVIVAL.

Gene Expression for Chemokine Receptors Influences Survival of Non-Hodgkin Lymphoma Patients

HHV-6 Reactivation Lowers the Risk of Acute Graft-Versus-Host Disease but Enhances the Risk of Infections Due to Activation of CD4+FoxP3+ Lymphocytes.

Proportion of IL-17A Producing CD4+ Cells Increases in Response to Alloreactivity as Part of a Network Involving Memory and Regulatory Cells Post HSCT.

Increase in Proportion of Th-17 Lymphocytes in Blood Heralds Overt Acute Graft Versus Host Disease in HSCT Patients.

Increased Interleukin-17 Proportion in Helper T Cell (Th17) in Patients Post Allogeneic Hematopoietic Stem Cell Transplantation.

CCL2 Chemokine Gene Expression in Lymph Nodes May Have Prognostic Value in Non-Hodgkin’s Lymphoma.

CCR5 Chemokine Receptor Expression Can Promote Disease Progression in Non-Hodgkin’s Lymphoma.

A High Proportion of CD4+CD25+ Lymphocytes Associates with a Risk of aGvHD and Inversely Correlate with Proportions of CMV and EBV Specific CD8+ Cells in Blood.

Low Dose Busulfan and ATG with Fludarabine as Conditioning Regimen Was Effective in Sibling and Unrelated Donor HSCT in CML Patients.

An Evidence That Mesenchymal Stem Cells Are Not Replaced by Peripheral Blood Stem Cell Allografts in CML Patients.

Marrow Cells Cultured in MSC Medium Expand to CD73, CD90 and CD105 Cells of Fibroblast-Like Morphology.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only